Loading…
Serum S100B Determination in the Management of Pediatric Mild Traumatic Brain Injury
The place of serum S100B measurement in mild traumatic brain injury (mTBI) management is still controversial. Our prospective study aimed to evaluate its utility in the largest child cohort described to date. Children younger than 16 years presenting at a pediatric emergency department within 3 h af...
Saved in:
Published in: | Clinical chemistry (Baltimore, Md.) Md.), 2012-07, Vol.58 (7), p.1116-1122 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The place of serum S100B measurement in mild traumatic brain injury (mTBI) management is still controversial. Our prospective study aimed to evaluate its utility in the largest child cohort described to date.
Children younger than 16 years presenting at a pediatric emergency department within 3 h after TBI were enrolled prospectively for blood sampling to determine serum S100B concentrations. The following information was collected: TBI severity determined by using the Masters classification [1: minimal or Glasgow Coma Scale (GCS) 15, 2: mild or GCS 13-15, and 3: severe or GCS |
---|---|
ISSN: | 0009-9147 1530-8561 |
DOI: | 10.1373/clinchem.2011.180828 |